We are live on
!
Find out more
AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
119 hedge funds and large institutions have $683M invested in Accelerate Diagnostics in 2017 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 51 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
264% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 14
263% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 8
39% more capital invested
Capital invested by funds: $493M → $683M (+$190M)
21% more funds holding
Funds holding: 98 → 119 (+21)
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
20% less call options, than puts
Call options by funds: $7.96M | Put options by funds: $9.98M
Holders
119
Holders Change
+21
Holders Change %
+21.43%
% of All Funds
2.97%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.15%
New
29
Increased
51
Reduced
14
Closed
8
Calls
$7.96M
Puts
$9.98M
Net Calls
-$2.03M
Net Calls Change
+$2.39M
Top Buyers
| 1 |
PC
Polar Capital
London,
United Kingdom
|
+$21.8M |
| 2 |
MGM
Miura Global Management
New York
|
+$14.1M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$12.7M |
| 4 |
Axa
Paris,
France
|
+$8.36M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$7.55M |
